Login

Workiva and Microsoft A connected reporting experience | Dave Mulcahy, CEO, Workiva IncWK:NYQ 00:10:00

Share On Facebook Share On Twitter

Dave Mulcahy is the CEO of this renowned company

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Sudbury's Environmental Recovery from Mining Impact
00:10:00
Advancing Precision Therapies for Kidney Diseases: Chinook's Pipeline and Clinical Progress Overview | Eric Dobmeier, CEO, Chinook Therapeutics Inc.
00:10:00
NioBay Metals: Advancing the James Bay Niobium Project and Raising Investor Awareness
00:10:00
Debunking Common Investment Myths: The Risks of Market Timing |Lauren Zangardi Haynes, Founder, Spark Financial Advisors, LLC.
00:10:00
Differentiated diverse capabilities Customized to your needs by specialist teams|Kathryn A. Vorisek,Senior Managing Director,Mesirow Financial Consulting
00:10:00
Brown Wealth Management: Legacy Planning and Heritage Design | Timothy Brown - President of Brown Wealth Management, LLC
00:10:00
RooLife Group's Bryan Carr on Using Technology to Expand Global Brand Reach | Bryan Carr, CEO, RooLife Group Ltd.
00:10:00
Breaking the Stigma: Addressing Mental Health and Addiction in the Workplace | Christopher J. Swift, CEO , The Hartford.
00:10:00
Navigating Innovation and Customer Care in the Hearing Care Sector|Enrico Vita , CEO, Amplifon Spa .
00:10:00
Vincenzo Guareschi Geddes da Filicaia at EnVent Winter Conference: Tenax International's Strategic Vision | Vincenzo Guareschi Geddes da Filicaia, President , Tenax International S.p.A.
00:10:00
"Insights on B-HY (AI) and Fixed Income Strategies: Key Takeaways from AXA Investment Managers at BBLAM Investment Forum 2024"
00:10:00
Transformative Therapies for Autoimmune Diseases|Carl Magnus Hogerkorp,CEO,Cyxone

© 2026 Nehu